Dexmethylphenidate Hydrochloride
Dexmethylphenidate Hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Dexmethylphenidate Hydrochloride; Generic name: DEXMETHYLPHENIDATE HYDROCHLORIDE; Manufacturer: Bryant Ranch Prepack.
| Brand name | Dexmethylphenidate Hydrochloride |
|---|---|
| Generic name | DEXMETHYLPHENIDATE HYDROCHLORIDE |
| Manufacturer | Bryant Ranch Prepack |
| Used for | 1 INDICATIONS AND USAGE Dexmethylphenidate hydrochloride extended-release is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies ( 14 )]. Dexmethylphenidate hydrochloride extended-release is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) ( 1 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION Patients new to methylphenidate: Recommended starting dose is 5 mg once daily for pediatric patients and 10 mg once daily for adults with or without food in the morning ( 2.2) . Patients currently on methylphenidate: Dexmethylphenidate hydrochloride extended-release dosage is half (1/2) the current total daily dosage of methylphenidate ( 2.2 ). Patients currently on dexmethylphenidate immediate-release tablets: Give the same daily dose of dexmethylphenidate hydrochlor |
| Warnings | WARNING: ABUSE, MISUSE, AND ADDICTION Dexmethylphenidate hydrochloride extended-release has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including dexmethylphenidate hydrochloride extended-release, can result in overdose and death [see Overdosage ( 10 )], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection. Before prescr |
| Active ingredient(s) | DEXMETHYLPHENIDATE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06bcef7a-b321-4dd8-9bf6-5d8f8940f04a |